A proper clinical evaluation of patients with Multiple Sclerosis (MS) is of great importance to
detect MS progression. It provides important data for physicians on their daily practice as …

Background There are a number of instruments that describe severity and progression of
multiple sclerosis and they are increasingly used as endpoints to assess the effectiveness of …

Clinical assessment of outcome in Multiple Sclerosis (MS) patients is problematic since the
disease can affect different aspects of the central nervous system and follow a variable …

Attempting to measure the impact of multiple sclerosis (MS) on the individuals patients has
become a major issue stimulated by both the emergence of new therapeutic agents and the …

Clinical outcome assessment in Multiple Sclerosis (MS) is challenging due to the diversity
and fluctuating nature of MS symptoms. Traditional clinical scales such as the EDSS are …

The measurement of the clinical manifestations of multiple sclerosis (MS) is difficult. In the
present study, we examined the changes in measurement of functions during and after pulse …

Background Progression in disability as measured by increase in the Expanded Disability
Status Scale (EDSS) is commonly used as outcome variable in clinical trials concerning …

Objective: To assess whether the age at which multiple sclerosis (MS) patients reach
Expanded Disability Status Scale (EDSS) milestones changed as long as new drugs for the …

Multiple sclerosis (MS) is a chronic inflammatory and neurodegenerative disease with both
clinical and pathological heterogeneity. The complexity of the MS population has offered …

Traditional outcome measures for patients with multiple sclerosis (MS), whether in clinical
trials or clinical practice, are currently in question. The combination of relapses, physical …